Case Report

Metastasis of Ewing Sarcoma to the Pancreas: Case Report and Literature Review

Table 1

Summary of recent cases of Ewing sarcoma FT of the pancreas in the literature.

AuthorAgeGenderSymptomPathologic featuresCytogeneticsPrimary/metastaticLocationSize (cm)TreatmentProgression/outcomeRef.

Present case29MNoneCD99EWSR1-FLI1 fusion (type 1)Metastatic—primary at the right tricep with metastases to the right lung, right greater sphenoid, and most recently to the pancreasBody and neckCyclophosphamide, topotecan, and RAD12 mos; later; NEDPresent case

Nishizawa et al. (2015)22MUpper abdominal pain, nausea, and vomitingCD99, NSE, VIM, synaptophysin, and neural cell adhesion molecule22q11 rearrangementPrimaryPancreatic headWhipple, CHE, and RAD12 mos; AWD[5]

Rubin et al. (1985)28MNoneN/AN/AMetastatic—primary ES of the right pubic bone with recurrence in 3 years and metastasis to the pancreasCHE and RAD8 mos; died of disease[10]

Obuz et al. (2000)15FJaundiceCD99Metastatic—primary ES in the right hemithorax invading mediastinumHeadN/APartial pancreatic resectionN/A[12]

Mulligan et al. (1997)26MNonePASMetastatic—primary tumor in the left femur and concurrent mass found in the pancreasBody and tailN/ARAD and chemotherapy15 mos; recurrence, DOD[13]

Bose et al. (2012)31FGallstone pancreatitisCD99 and VIMEWSR1 gene at 22q12 (FISH)Primary ES in the pancreasPosterior junction of the body and tail3Distal pancreatectomy, splenectomy, and VAC with alternating IE18 mos; NED[14]

Kent et al. (2018)72FJaundiceCD99 and PAS granulesN/APrimaryPapilla of VaterWhipple2 mos; DOD[15]

Komforti et al. (2018)39MAbdominal painCD99, chromogranin, and synaptophysinEWSR1-FLI1PrimaryPancreatic bodyPain control1 mo; AD[16]

Liu et al. (2018)36MUpper abdominal pain and jaundiceCD99, Ki-67, VIM, β-catenin, alpha-1-antichymotrypsin, and S-100N/APrimaryHeadRoux-en-Y choledochojejunostomy, refused RAD and CHE1 mo; liver metastasis, 2 mos; DOD[17]

Golhar et al. (2017)17FJaundice and itchingCD99 and cytokeratin AE1/AE3PrimaryPancreatic head and uncinate processPancreotoduodectomy, vincristine, cyclophosphamide, and doxorubicin2 wks; AWD[18]

Saif et al. (2017)38FAbdominal painCD99t(11;22), (q24; q12)PrimaryBody and tail of the pancreasDistal pancreatectomy, IE, and VAC6 mos; AWD[19]

Teixeira et al. (2015)28FEpigastric pain, jaundice, and pruritusCD99, VIM, automated CKM, and CD56PrimaryHead and bodyGastroduodenopancreatectomyNED postop[20]

Changal et al. (2014)60MEpigastric painCD99, NSE, FLI-1, synaptophysin, and VIMt(11;22) (q24; q12) via FISHPrimaryHead3 mos; AWD[21]

Dias et al. (2013)25FAbdominal painCD99 and cytokeratin 8t(11;22) (q24; q12) translocationPrimaryHeadPancreaticoduodenectomy, VAI, and VDC8 mos; DOD[22]

Jayant et al. (2013)20FLUQ painCD99PrimaryBody and tailDistal pancreatectomy and splenectomy, VAC, and RAD24 mos; DOD[23]

Mao et al. (2013)13FAbdominal pain, anorexia, polyuria, and polydipsiaCD99 and NSEEWSR1-FLI1 fusionPrimaryHeadSurgical resection of uncinate process, RAD, VAC, and MAID9 mos; metastasis to the liver, 36 mos; metastasis to the right kidney; 41 mos; metastasis to the 3rd vertebra, DOD[24]

Rao et al. (2012)47FAbdominal painCD99PrimaryBody and tailDistal pancreatectomy and splenectomy, IE, and VACNED after 2 cycles[25]

Reilly et al. (2013)23MUpper abdominal pain, nauseaCD99, cytokeratin AE1/AE3, Cam 5.2, CK19, VIM, BCL-2, NSE, EMA, cyclin D1, and PAS granulesEWSR1-FLT1PrimaryDistal body and proximal tailDistal pancreatectomy and splenectomyUnknown[26]

Jing et al. (2011)24FNoneN/AN/APrimaryHeadResection and CHEN/A[27]

Maxwell et al. (2011)11MFatigueCD99, broad-spectrum cytokeratin, and VIMEWSR1-ERG fusion (RT-PCR)PrimaryHeadVDC alternating with IE, Whipple3 mos; AWD[28]

Wakao et al. (2011)3MUpper abdominal pain and swellingN/AN/AN/AHeadN/APancreatoduodenectomy, VDC/IE, AST, and RAD8 mos; AWD[29]

Doi et al. (2009)37MJaundiceCD99, VIM, CD56, and NSEEWSR1 rearrangement at 22q12PrimaryHead6Pancreatoduodecotomy, hepatic resection, alternating with IE, RAD12 mos; NED[30]

Menon et al. (2006)8FAbdominal pain, menstrual bleeding, breast development, and pubic hairCD99N/APrimaryBodyCholecystectomy, doxorubicin, and RADCR postop, 19; death 2/2 to heart failure[31]

Schutte et al. (2006)2FVaginal bleeding, breast development, and pubic hairSynaptophysin, CD99, chromogranin A, S-100, VIM, estrogen receptor, progesterone receptor, inhibin, and epithelial membrane antigenN/APrimaryBodyDistal pancreatectomy, vincristine, adriamycin, and cyclophosphamide (VDC) alternating with cisplatin and etoposide12 mos; NED[32]

Welsch et al. (2006)33MAbdominal pain and vomitingCD99, VIM, NSE, cytokeratin, EMA, synaptophysin, CD56, and CD117Translocation involving EWS gene at 22q12PrimaryBody and tailPartial gastric resection, left pancreatic resection, splenectomy, , , and AST1 mo; metastases to the liver, 12 mos, NED[33]

Perek et al. (2003)31MRUQ painCD99, VIM, Leu 7, and synaptophysinPrimaryHead and bodyWhipple, , , doxorubicin, and docetaxel4 mos; local recurrence, 24/36 mos; metastasis to the right lung, 50 mos; DOD[34]

Takeuchi et al. (2003)10FUpper abdominal painN/AN/AN/ABodyN/ACHE and AST3 mos; DOD[35]

Gemechu et al. (2002)17MAbdominal swellingSynaptophysin and chromograninPrimaryBodyN/AN/A36 mos; AWD[36]

Movahedi-Lankarani et al. (2002)17MAbdominal pain and jaundiceCD99, cytokeratin AE1/AE3, and NSEt(11;22) (q24; q12)PrimaryHead9.0Whipple and CHE33 mos; NED[37]
20MAbdominal pain and jaundiceCD99, cytokeratin AE1/AE3, NSE, and epithelial membrane antigent(11;22) (q24; q12)PrimaryHead3.5Whipple27 mos; AWD[37]
25FAbdominal painCD99 and cytokeratin AE1/AE3N/APrimaryHeadN/AN/A[37]
21FAbdominal painCD99, cytokeratin AE1/AE3, NSE, chromogranin, synaptophysin, and epithelial membrane antigent(11;22) (q24; q12)PrimaryHeadN/AWhippleDeath due to OR complication[37]
25FAbdominal pain and jaundiceCD99 and NSEPrimaryHead8.0N/A[37]
13MAbdominal painCD99 and NSEN/APrimaryHead6.0VDC43 mos; NED[37]
6MAbdominal pain and jaundiceCD99, cytokeratin AE1/AE3, NSE, and synaptophysint(11;22) (q24; q12)PrimaryHead3.5Whipple and VDC48 mos; recurrence, DOD[37]

O’Sullivan et al. (2001)20MNoneCD99, VIM cytokeratin, and membrane antigenEWS-7 to Fli1-5PrimaryHead3.5Pancreatoduodenectomy, CHE, and RADMetastasis to the lungs at 30 mos, AWD[38]

Bulchmann et al. (2000)6FPaleness, dizziness, and fatigueCD99, pancytokeratin, NSE, gamma-enolase and squamoid corpuscles, and S-100Loss of cosmids F7 and E4 distal EWSR1 breakpointPrimaryHeadWhipple and colon segmentectomy (refused CHE)6 mos; recurrence, DOD[39]

Luttges et al. (1997)13FDyspepsia and exophthalmosCD99 and NSEN/ABody and tailWhipple and CHE2 mos; AWD[40]
31MUpper abdominal painCD99, NSE, and vimentinN/ABodyN/ACHE and resectionN/A[40]

Danner et al. (1994)17MUpper abdominal painCytokeratin, NSE, and 12E7t(11;12) (q24; q12)PrimaryHeadN/APancreatoduodenectomy, VDC/cisplatin+etoposide, and RAD33 mos; AWD[41]

AI = adriamycin (doxorubicin)/ifosfamide; IE = ifosphamide and etoposide; VAC = vincristine, adriamycin, and cyclophosphamide; VDC = vincristine, doxorubicin and cyclophosphamide; RAD = radiation; VIDE = vincristine, ifosfamide, doxorubicin, and etoposide; VAI = vincristine, actinomycin D and ifosfamide; CR = complete remission; AST = autologous stem transplant; MAID = doxorubicin/dacarvazine/ifosfamide; AWD = alive without disease; DOD = died of disease; DOC = died of complications; AD = alive with disease; NED = no evidence of disease; CHE = chemotherapy (specific agents unknown); NSE = neuronspecific antigen; VIM = vimentin.